AMGEN INC (AMGN) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 2021 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary: Amgen Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2021 to 2023.
Amgen Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $7.86 B, a 6.93% increase from 2022.
Amgen Inc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $7.35 B, a 9.63% increase from 2021.

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual Data (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$7.86 B	+$509 M	+6.93%	Jan 1, 2023	Dec 31, 2023	10-K	2024-02-14
2022	$7.35 B	+$645 M	+9.63%	Jan 1, 2022	Dec 31, 2022	10-K	2024-02-14
2021	$6.7 B			Jan 1, 2021	Dec 31, 2021	10-K	2024-02-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.